Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2...
08 Mai 2020 - 1:00PM
Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX:
EMHTF) today announced that, further to its news release on April
29th, Emerald will report audited financial results for the fourth
quarter and year ended December 31, 2019 after the market close on
Wednesday, May 13, 2020. The company will host a conference
call on Thursday, May 14, 2020, at 10:30 a.m. ET.
To access the audio broadcast, please dial (866) 652-5200, or
via the internet at:
https://services.choruscall.com/links/emhtf200514.html An archived
version of the presentation will be available for 90 days on the
“Investors” section of Emerald’s website:
https://ir.emeraldhealth.ca/events-and-presentations
Emerald also announces that it has issued an
aggregate of 1,500,000 stock options to directors at an exercise
price of $0.165 per common share for a period of 5 years. All stock
options will vest immediately.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc. is committed
to cutting-edge cannabis science to create new consumer experiences
with distinct recreational, medical and wellness-oriented cannabis
and non-cannabis products. With an emphasis on innovation and
production excellence, Emerald’s three distinct operating assets
are designed to uniquely serve the Canadian marketplace and
international opportunities. These assets, all in full production,
include: its Richmond, BC-based greenhouse operation (78,000 square
feet) capable of producing organic-certified product; Verdélite,
its premium craft cannabis production indoor facility in St.
Eustache, Québec (88,000 square foot); and Pure Sunfarms, its
41.3%-owned joint venture in Delta, BC, producing high quality,
affordably priced products (1.1 million square feet). Its Emerald
Naturals joint venture has launched a new natural wellness product
category with its non-cannabis endocannabinoid-supporting product
line and is expanding distribution across Canada.
Please visit www.emeraldhealth.ca for more information
or contact: Jenn Hepburn, Chief Financial Officer (800) 757 3536
Ext. #5
Emerald Investor Relations (800) 757 3536 Ext. #5
invest@emeraldhealth.ca
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking
Statements: Certain statements made in this press release that are
not historical facts are forward-looking statements and are subject
to important risks, uncertainties and assumptions, both general and
specific, which give rise to the possibility that actual results or
events could differ materially from our expectations expressed in
or implied by such forward-looking statements.
We cannot guarantee that any forward-looking
statement will materialize, and readers are cautioned not to place
undue reliance on these forward-looking statements. These
forward-looking statements involve risks and uncertainties related
to, among other things, changes of law and regulations; changes of
government; failure to obtain regulatory approvals or permits;
failure to obtain necessary financing; results of production and
sale activities; results of scientific research; regulatory
changes; changes in prices and costs of inputs; demand for labour;
demand for products; failure of counter-parties to perform
contractual obligations; as well as the risk factors described in
Emerald’s annual information form and other regulatory filings. The
forward-looking statements contained in this press release
represent our expectations as of the date hereof. Forward-looking
statements are presented for the purpose of providing information
about management's current expectations and plans and allowing
investors and others to obtain a better understanding of our
anticipated operating environment. Readers are cautioned that such
information may not be appropriate for other purposes. Emerald
undertakes no obligations to update or revise such statements to
reflect new circumstances or unanticipated events as they occur,
unless required by applicable law.
Emerald Health Therapeut... (TSXV:EMH)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Emerald Health Therapeut... (TSXV:EMH)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024